The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis.
<h4>Background</h4>Glial fibrillary acidic protein (GFAP) is a specific intermediate filament of the cytoskeleton of the astrocyte and may be used as a specific marker for astrocytic damage. It is detectable in the cerebrospinal fluid following a relapse caused by Multiple Sclerosis (MS)...
Saved in:
Main Authors: | Mithu Storoni, Axel Petzold, Gordon T Plant |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/5cd30cbea96c47ef9541b7c31f50deaa |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
by: Tian-Xiang Zhang, et al.
Published: (2021) -
Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis
by: Merle H, et al.
Published: (2013) -
Cytokines and chemokines expression in serum of patients with neuromyelitis optica
by: Ai NP, et al.
Published: (2019) -
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
by: Bo Chen, et al.
Published: (2017) -
Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer
by: Yuan J, et al.
Published: (2019)